Your browser doesn't support javascript.
loading
Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation.
Cheng, Wen-Han; Chao, Tze-Fan; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Tuan, Ta-Chuan; Liao, Jo-Nan; Chung, Fa-Po; Lip, Gregory Y H; Chen, Shih-Ann.
Affiliation
  • Cheng WH; From the Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taiwan (W.-H.C., T.-F.C., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., J.-N.L., F.-P.C., S.-A.C.).
  • Chao TF; Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan (W.-H.C., T.-F.C., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., J.-N.L., F.-P.C., S.-A.C.).
  • Lin YJ; From the Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taiwan (W.-H.C., T.-F.C., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., J.-N.L., F.-P.C., S.-A.C.).
  • Chang SL; Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan (W.-H.C., T.-F.C., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., J.-N.L., F.-P.C., S.-A.C.).
  • Lo LW; From the Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taiwan (W.-H.C., T.-F.C., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., J.-N.L., F.-P.C., S.-A.C.).
  • Hu YF; Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan (W.-H.C., T.-F.C., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., J.-N.L., F.-P.C., S.-A.C.).
  • Tuan TC; From the Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taiwan (W.-H.C., T.-F.C., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., J.-N.L., F.-P.C., S.-A.C.).
  • Liao JN; Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan (W.-H.C., T.-F.C., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., J.-N.L., F.-P.C., S.-A.C.).
  • Chung FP; From the Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taiwan (W.-H.C., T.-F.C., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., J.-N.L., F.-P.C., S.-A.C.).
  • Lip GYH; Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan (W.-H.C., T.-F.C., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., J.-N.L., F.-P.C., S.-A.C.).
  • Chen SA; From the Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taiwan (W.-H.C., T.-F.C., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., J.-N.L., F.-P.C., S.-A.C.).
Stroke ; 50(9): 2574-2577, 2019 09.
Article in En | MEDLINE | ID: mdl-31288672
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Atrial Fibrillation / Stroke / Intracranial Hemorrhages / Factor Xa Inhibitors / Rivaroxaban Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Stroke Year: 2019 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Atrial Fibrillation / Stroke / Intracranial Hemorrhages / Factor Xa Inhibitors / Rivaroxaban Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Stroke Year: 2019 Type: Article